COVID-19 vaccination significantly lowers the risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit in infants during the first month after birth.

An international study of COVID-19 in pregnancy, which included Ann & Robert H. Lurie Children's Hospital of Chicago, found that neonates of booster-vaccinated mothers had less risk of being infected ...

A new research study shows that hepatitis B vaccination rates among newborns in the U.S. declined by more than 10 percent from its peak in early 2023. The study, published online Tuesday in the ...

A major international study has assessed key bacterial targets that could form the basis of a new maternal vaccine to protect newborns from life-threatening infections. The University of Strathclyde ...

Safe and effective vaccines against HBV have been available since 1982. Vaccines available in the United States use recombinant DNA technology to express hepatitis B surface antigen (HBsAg) in yeast; ...

Researchers from Children's Hospital of Philadelphia (CHOP) found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, ...

Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, ...

Through a successful vaccination campaign, South Sudan and Sudan have achieved Maternal and Neonatal Tetanus Elimination (MNTE), a significant public health milestone.

A targeted birth-dose vaccine recommendation for hepatitis B virus in the United States would likely increase neonatal infections.

In 2023, the World Health Organization announced that Mali had successfully eliminated maternal and neonatal tetanus (MNT), an excruciating disease that kills tens of thousands of infants every year.